- Elotuzumab
drugbox-mab
source = Humanized
target = CS1 (CD319)
CAS_number = 915296-00-3
ATC_prefix =
ATC_suffix =
PubChem =
DrugBank =
C=6476 | H=9982 | N=1714 | O=2016 | S=42
molecular_weight = 145.5 kDa
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =Elotuzumab (also known as HuLuc63) is a novel humanized
monoclonal antibody which is presently under phase I clinical investigation in relapsed multiple myeloma. [cite web |url=http://www.pdl.com/index.cfm?navId=176 |title=PDL BioPharma, Development Pipeline - HuLuc63 |accessdate=2008-08-14 |format= |work= ]References
External links
* [http://www.pdl.com/index.cfm?navId=176 Official website]
Wikimedia Foundation. 2010.